Growth factors in tumor microenvironment

Frontiers in Bioscience

Volumn 15, Issue 1, 2010, Pages 151-165

  Zhang, Xuejing ^a   Nie, Daotai ^a   Chakrabarty, Subhas ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EGFR; FGF; Growth factor; PDGF; Review; Tumor microenvironment

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANIMAL; BIOLOGICAL MODEL; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

ANIMALS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTORS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 77951227016     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3612     Document Type: Article

References (88)

1. Wang, H., V. Radjendirane, K. K. Wary & S. Chakrabarty: Transforming growth factor beta regulates cell-cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells. Oncogene, 23, 5558-61 (2004). (Pubitemid 39044067)
2. Wang, H. & S. Chakrabarty: Requirement of protein kinase Calpha, extracellular matrix remodeling, and cellmatrix interaction for transforming growth factorbetaregulated expression of E-cadherin and catenins. J Cell Physiol, 187, 188-95 (2001). (Pubitemid 32270077)
3. Lunt, S. J., N. Chaudary & R. P. Hill: The tumor microenvironment and metastatic disease. Clin Exp Metastasis (2008).
4. Bhowmick, N. A., E. G. Neilson & H. L. Moses: Stromal fibroblasts in cancer initiation and progression. Nature, 432, 332-7 (2004). (Pubitemid 39551661)
5. Coussens, L. M. & Z. Werb: Inflammation and cancer. Nature, 420, 860-7 (2002). (Pubitemid 36019639)
6. Hughes, F. J., W. Turner, G. Belibasakis & G. Martuscelli: Effects of growth factors and cytokines on osteoblast differentiation. Periodontol 2000, 41, 48-72 (2006). (Pubitemid 43937565)
7. Barr, S., S. Thomson, E. Buck, S. Russo, F. Petti, I. Sujka-Kwok, A. Eyzaguirre, M. Rosenfeld-Franklin, N. W. Gibson, M. Miglarese, D. Epstein, K. K. Iwata & J. D. Haley: Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clin Exp Metastasis, 25, 685-93 (2008).
8. Kim, H. J., B. C. Litzenburger, X. Cui, D. A. Delgado, B. C. Grabiner, X. Lin, M. T. Lewis, M. M. Gottardis, T. W. Wong, R. M. Attar, J. M. Carboni & A. V. Lee: Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol Cell Biol, 27, 3165-75 (2007). (Pubitemid 46581327)
9. Elenbaas, B. & R. A. Weinberg: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res, 264, 169-84 (2001). (Pubitemid 32989090)
10. Frasca, F., G. Pandini, L. Sciacca, V. Pezzino, S. Squatrito, A. Belfiore & R. Vigneri: The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem, 114, 23-37 (2008). (Pubitemid 351998752)
11. Peretz, S., C. Kim, S. Rockwell, R. Baserga & P. M. Glazer: IGF1 receptor expression protects against microenvironmental stress found in the solid tumor. Radiat Res, 158, 174-80 (2002). (Pubitemid 34851812)
12. Normanno, N. & W. J. Gullick: Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application? Endocr Relat Cancer, 13, 3-6 (2006).
13. Olayioye, M. A., R. M. Neve, H. A. Lane & N. E. Hynes: The ErbB signaling network: receptor heterodimerization in development and cancer. Embo J, 19, 3159-67 (2000). (Pubitemid 30428195)
14. Baselga, J. & C. L. Arteaga: Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol, 23, 2445-59 (2005). (Pubitemid 47050835)
15. Yarden, Y.: The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer, 37 Suppl 4, S3-8 (2001). (Pubitemid 32938123)
16. Normanno, N., A. De Luca, C. Bianco, L. Strizzi, M. Mancino, M. R. Maiello, A. Carotenuto, G. De Feo, F. Caponigro & D. S. Salomon: Epidermal growth factor receptor (EGFR) signaling in cancer. Gene, 366, 2-16 (2006). (Pubitemid 43199589)
17. Franovic, A., L. Gunaratnam, K. Smith, I. Robert, D. Patten & S. Lee: Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc Natl Acad Sci U S A, 104, 13092-7 (2007). (Pubitemid 351737598)
18. Chan, D. A. & A. J. Giaccia: Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev, 26, 333-9 (2007). (Pubitemid 47101666)
19. Goldoni, S. & R. V. Iozzo: Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer, 123, 2473-9 (2008).
20. Morinaga, R., I. Okamoto, Y. Fujita, T. Arao, M. Sekijima, K. Nishio, H. Ito, M. Fukuoka, J. I. Kadota & K. Nakagawa: Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer. Cancer Sci (2008).
21. Jeon, Y. K., S. W. Sung, J. H. Chung, W. S. Park, J. W. Seo, C. W. Kim & D. H. Chung: Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer. Lung Cancer, 54, 387-98 (2006). (Pubitemid 44754719)
22. Vaupel, P.: The role of hypoxia-induced factors in tumor progression. Oncologist, 9 Suppl 5, 10-7 (2004). (Pubitemid 39658341)
23. Swinson, D. E. & K. J. O'Byrne: Interactions between hypoxia and epidermal growth factor receptor in non-smallcell lung cancer. Clin Lung Cancer, 7, 250-6 (2006). (Pubitemid 43280027)
24. Lieubeau-Teillet, B., J. Rak, S. Jothy, O. Iliopoulos, W. Kaelin & R. S. Kerbel: von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids. Cancer Res, 58, 4957-62 (1998). (Pubitemid 28503696)
25. Wang, T., T. Niki, A. Goto, S. Ota, T. Morikawa, Y. Nakamura, E. Ohara, S. Ishikawa, H. Aburatani, J. Nakajima & M. Fukayama: Hypoxia increases the motility of lung adenocarcinoma cell line A549 via activation of the epidermal growth factor receptor pathway. Cancer Sci, 98, 506-11 (2007). (Pubitemid 46562740)
26. Harris, A. L.: Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer, 2, 38-47 (2002). (Pubitemid 37328806)
27. Rofstad, E. K.: Microenvironment-induced cancer metastasis. Int J Radiat Biol, 76, 589-605 (2000). (Pubitemid 30345160)
28. Subarsky, P. & R. P. Hill: The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis, 20, 237-50 (2003). (Pubitemid 36513228)
29. Tang, Y., L. Olufemi, M. T. Wang & D. Nie: Role of Rho GTPases in breast cancer. Front Biosci, 13, 759-76 (2008). (Pubitemid 351599780)
30. Hanahan, D. & R. A. Weinberg: The hallmarks of cancer. Cell, 100, 57-70 (2000). (Pubitemid 30046295)
31. Woodhouse, E. C., R. F. Chuaqui & L. A. Liotta: General mechanisms of metastasis. Cancer, 80, 1529-37 (1997). (Pubitemid 27444024)
32. LeBedis, C., K. Chen, L. Fallavollita, T. Boutros & P. Brodt: Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer, 100, 2- 8 (2002). (Pubitemid 34602057)
33. Sasaki, T., T. Nakamura, R. B. Rebhun, H. Cheng, K. S. Hale, R. Z. Tsan, I. J. Fidler & R. R. Langley: Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model. Am J Pathol, 173, 205-16 (2008). (Pubitemid 351947968)
34. Pu, J., C. D. McCaig, L. Cao, Z. Zhao, J. E. Segall & M. Zhao: EGF receptor signalling is essential for electric-fielddirected migration of breast cancer cells. J Cell Sci, 120, 3395-403 (2007). (Pubitemid 350028347)
35. Wei, Q., L. Chen, L. Sheng, H. Nordgren, K. Wester & J. Carlsson: EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases. Int J Oncol, 31, 493-9 (2007).
36. De Luca, A., A. Carotenuto, A. Rachiglio, M. Gallo, M. R. Maiello, D. Aldinucci, A. Pinto & N. Normanno: The role of the EGFR signaling in tumor microenvironment. J Cell Physiol, 214, 559-67 (2008). (Pubitemid 351224199)
37. Yi, T., H. L. Lee, J. H. Cha, S. I. Ko, H. J. Kim, H. I. Shin, K. M. Woo, H. M. Ryoo, G. S. Kim & J. H. Baek: Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. J Cell Physiol, 217, 409-22 (2008).
38. Bruzzaniti, A. & R. Baron: Molecular regulation of osteoclast activity. Rev Endocr Metab Disord, 7, 123-39 (2006). (Pubitemid 46044352)
39. Zhu, J., X. Jia, G. Xiao, Y. Kang, N. C. Partridge & L. Qin: EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. J Biol Chem, 282, 26656-64 (2007). (Pubitemid 47501956)
40. Normanno, N., A. De Luca, D. Aldinucci, M. R. Maiello, M. Mancino, A. D'Antonio, R. De Filippi & A. Pinto: Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis. Endocr Relat Cancer, 12, 471-82 (2005). (Pubitemid 40896460)
41. Symons, A. L.: Reduced growth hormone receptor immunoreactivity in osteoclasts adjacent to the erupting molar in the incisor-absent (osteopetrotic) rat. Eur J Oral Sci, 111, 503-9 (2003). (Pubitemid 38010976)
42. Krampera, M., A. Pasini, A. Rigo, M. T. Scupoli, C. Tecchio, G. Malpeli, A. Scarpa, F. Dazzi, G. Pizzolo & F. Vinante: HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood, 106, 59-66 (2005). (Pubitemid 40967175)
43. Angelucci, A., C. Festuccia, G. L. Gravina, P. Muzi, L. Bonghi, C. Vicentini & M. Bologna: Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate, 59, 157-66 (2004). (Pubitemid 38481227)
44. Hobisch, A., M. Fiechtl, B. Sandahl-Sorensen, S. Godoy-Tundidor, E. Artner-Dworzak, R. Ramoner, G. Bartsch & Z. Culig: Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression. Prostate, 59, 401-8 (2004). (Pubitemid 38661807)
45. Hocking, A. M., T. Shinomura & D. J. McQuillan: Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol, 17, 1-19 (1998). (Pubitemid 28206020)
46. Ruhland, C., E. Schonherr, H. Robenek, U. Hansen, R. V. Iozzo, P. Bruckner & D. G. Seidler: The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis. Febs J, 274, 4246-55 (2007). (Pubitemid 47228640)
47. Santra, M., I. Eichstetter & R. V. Iozzo: An antioncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem, 275, 35153-61 (2000).
48. Reed, C. C., A. Waterhouse, S. Kirby, P. Kay, R. T. Owens, D. J. McQuillan & R. V. Iozzo: Decorin prevents metastatic spreading of breast cancer. Oncogene, 24, 1104- 10 (2005). (Pubitemid 40313888)
49. Zhu, J. X., S. Goldoni, G. Bix, R. T. Owens, D. J. McQuillan, C. C. Reed & R. V. Iozzo: Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem, 280, 32468-79 (2005). (Pubitemid 41361859)
50. Seidler, D. G., S. Goldoni, C. Agnew, C. Cardi, M. L. Thakur, R. T. Owens, D. J. McQuillan & R. V. Iozzo: Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem, 281, 26408-18 (2006). (Pubitemid 44401849)
51. Kan, M., F. Uematsu, X. Wu & F. Wang: Directional specificity of prostate stromal to epithelial cell communication via FGF7/FGFR2 is set by cell- and FGFR2 isoform-specific heparan sulfate. In vitro Cell Dev Biol Anim, 37, 575-7 (2001). (Pubitemid 33035456)
52. Nomura, S., H. Yoshitomi, S. Takano, T. Shida, S. Kobayashi, M. Ohtsuka, F. Kimura, H. Shimizu, H. Yoshidome, A. Kato & M. Miyazaki: FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. Br J Cancer, 99, 305-13 (2008).
53. Wu, X., C. Jin, F. Wang, C. Yu & W. L. McKeehan: Stromal cell heterogeneity in fibroblast growth factormediated stromal-epithelial cell cross-talk in premalignant prostate tumors. Cancer Res, 63, 4936-44 (2003). (Pubitemid 37022629)
54. Chesi, M., L. A. Brents, S. A. Ely, C. Bais, D. F. Robbiani, E. A. Mesri, W. M. Kuehl & P. L. Bergsagel: Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood, 97, 729-36 (2001). (Pubitemid 32113407)
55. Tennant, T. R., H. Kim, M. Sokoloff & C. W. Rinker-Schaeffer: The Dunning model. Prostate, 43, 295-302 (2000). (Pubitemid 30367965)
56. Kwabi-Addo, B., M. Ozen & M. Ittmann: The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer, 11, 709-24 (2004). (Pubitemid 40065546)
57. Matrisian, L. M., G. R. Cunha & S. Mohla: Epithelialstromal interactions and tumor progression: meeting summary and future directions. Cancer Res, 61, 3844-6 (2001). (Pubitemid 32695002)
58. Yan, G., Y. Fukabori, G. McBride, S. Nikolaropolous & W. L. McKeehan: Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol, 13, 4513-22 (1993). (Pubitemid 23220358)
59. Cao, R., E. Brakenhielm, R. Pawliuk, D. Wariaro, M. J. Post, E. Wahlberg, P. Leboulch & Y. Cao: Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med, 9, 604-13 (2003). (Pubitemid 36597108)
60. Uematsu, F., J. H. Jang, M. Kan, F. Wang, Y. Luo & W. L. McKeehan: Evidence that the intracellular domain of FGF receptor 2IIIb affects contact of the ectodomain with two FGF7 ligands. Biochem Biophys Res Commun, 283, 791-7 (2001). (Pubitemid 32924649)
61. Jin, C., F. Wang, X. Wu, C. Yu, Y. Luo & W. L. McKeehan: Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in twocompartment premalignant prostate tumors. Cancer Res, 64, 4555-62 (2004). (Pubitemid 38856928)
62. Carmeliet, P. & R. K. Jain: Angiogenesis in cancer and other diseases. Nature, 407, 249-57 (2000).
63. Smith, K., S. B. Fox, R. Whitehouse, M. Taylor, M. Greenall, J. Clarke & A. L. Harris: Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival. Ann Oncol, 10, 707-13 (1999). (Pubitemid 29355089)
64. Weis, S. M., J. N. Lindquist, L. A. Barnes, K. M. Lutu-Fuga, J. Cui, M. R. Wood & D. A. Cheresh: Cooperation between VEGF and beta3 integrin during cardiac vascular development. Blood, 109, 1962-70 (2007). (Pubitemid 46348193)
65. Nicoli, S., G. De-Sena & M. Presta: Fibroblast Growth Factor 2-induced angiogenesis in zebrafish: the zebrafish yolk membrane (ZFYM) angiogenesis assay. J Cell Mol Med (2008).
66. Gerhardt, H. & C. Betsholtz: Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res, 314, 15-23 (2003). (Pubitemid 37409909)
67. Cao, Y., R. Cao & E. M. Hedlund: R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways. J Mol Med, 86, 785-9 (2008).
68. Nissen, L. J., R. Cao, E. M. Hedlund, Z. Wang, X. Zhao, D. Wetterskog, K. Funa, E. Brakenhielm & Y. Cao: Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest, 117, 2766-77 (2007). (Pubitemid 47529608)
69. Yan, W., B. Bentley & R. Shao: Distinct angiogenic mediators are required for basic fibroblast growth factorand vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis. Mol Biol Cell, 19, 2278-88 (2008).
70. Indraccolo, S., L. Stievano, S. Minuzzo, V. Tosello, G. Esposito, E. Piovan, R. Zamarchi, L. Chieco-Bianchi & A. Amadori: Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment. Proc Natl Acad Sci U S A, 103, 4216-21 (2006).
71. Nicoli, S. & M. Presta: The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc, 2, 2918-23 (2007).
72. Mitsiades, C. S., P. J. Hayden, K. C. Anderson & P. G. Richardson: From the bench to the bedside: emerging new treatments in multiple myeloma. Best Pract Res Clin Haematol, 20, 797-816 (2007). (Pubitemid 350215385)
73. Betsholtz, C., L. Karlsson & P. Lindahl: Developmental roles of platelet-derived growth factors. Bioessays, 23, 494- 507 (2001). (Pubitemid 32575610)
74. Heldin, C. H., U. Eriksson & A. Ostman: New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys, 398, 284-90 (2002). (Pubitemid 34848597)
75. Bissell, M. J., D. C. Radisky, A. Rizki, V. M. Weaver & O. W. Petersen: The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation, 70, 537-46 (2002). (Pubitemid 36194318)
76. Krtolica, A., S. Parrinello, S. Lockett, P. Y. Desprez & J. Campisi: Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A, 98, 12072-7 (2001). (Pubitemid 32959828)
77. Lederle, W., H. J. Stark, M. Skobe, N. E. Fusenig & M. M. Mueller: Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am J Pathol, 169, 1767-83 (2006). (Pubitemid 351182007)
78. Apte, M. V., S. Park, P. A. Phillips, N. Santucci, D. Goldstein, R. K. Kumar, G. A. Ramm, M. Buchler, H. Friess, J. A. McCarroll, G. Keogh, N. Merrett, R. Pirola & J. S. Wilson: Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas, 29, 179-87 (2004). (Pubitemid 39304974)
79. Farrow, B., D. Albo & D. H. Berger: The role of the tumor microenvironment in the progression of pancreatic cancer. J Surg Res, 149, 319-28 (2008).
80. Sangai, T., G. Ishii, K. Kodama, S. Miyamoto, Y. Aoyagi, T. Ito, J. Magae, H. Sasaki, T. Nagashima, M. Miyazaki & A. Ochiai: Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma. Int J Cancer, 115, 885-92 (2005). (Pubitemid 40791828)
81. Bachem, M. G., M. Schunemann, M. Ramadani, M. Siech, H. Beger, A. Buck, S. Zhou, A. Schmid-Kotsas & G. Adler: Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology, 128, 907-21 (2005). (Pubitemid 40523543)
82. McCarty, M. F., R. J. Somcio, O. Stoeltzing, J. Wey, F. Fan, W. Liu, C. Bucana & L. M. Ellis: Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. J Clin Invest, 117, 2114-22 (2007). (Pubitemid 47219556)
83. Sims, D. E.: Diversity within pericytes. Clin Exp Pharmacol Physiol, 27, 842-6 (2000).
84. Chen, Y., C. Miller, R. Mosher, X. Zhao, J. Deeds, M. Morrissey, B. Bryant, D. Yang, R. Meyer, F. Cronin, B. S. Gostout, K. Smith-McCune & R. Schlegel: Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res, 63, 1927-35 (2003). (Pubitemid 36460860)
85. Gius, D., M. C. Funk, E. Y. Chuang, S. Feng, P. C. Huettner, L. Nguyen, C. M. Bradbury, M. Mishra, S. Gao, B. M. Buttin, D. E. Cohn, M. A. Powell, N. S. Horowitz, B. P. Whitcomb & J. S. Rader: Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Res, 67, 7113-23 (2007). (Pubitemid 47206538)
86. Pietras, K., J. Pahler, G. Bergers & D. Hanahan: Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med, 5, e19 (2008).
87. Lee, T. J., O. Sartor, R. B. Luftig & S. Koochekpour: Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Mol Cancer, 3, 31 (2004).
88. Werth, C., D. Stuhlmann, B. Cat, H. Steinbrenner, L. Alili, H. Sies & P. Brenneisen: Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell-secreted platelet-derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation. Carcinogenesis, 29, 404-10 (2008). (Pubitemid 351359681)